TrialCancer chemotherapy and pharmacology2018

Model based analysis of the heterogeneity in the tumour size dynamics differentiates vemurafenib, dabrafenib and trametinib in metastatic melanoma.

Hitesh B Mistry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.